but big pharma and medical community not interested, as no patent can be obtained
#DCA (Dichloroacetic acid) is a generic #drug originally developed to treat metabolic disorders, and now in #human clinical trail in Canada for potential cancer treatment.
As DCA can not be patented, so bid pharma is not interested...
the research is conducted only on small public money and philanthropic foundations
Evangelos #Michelakis of the University of Alberta in Edmonton, Canada, and his colleagues tested DCA on human cells cultured outside the body and found that it killed lung, breast and brain cancer cells, but not healthy cells.
DCA attacks a unique feature of cancer cells: the fact that they make their energy throughout the main body of the cell, rather than in distinct organelles called mitochondria. This process, called glycolysis, is inefficient and uses up vast amounts of sugar.
DCA is widely available, easy to use and is much cheaper than the costly cancer drugs made by major pharmaceutical companies.
Until now it had been assumed that cancer cells used #glycolysis because their #mitochondria were irreparably damaged. However, Michelakis's experiments prove this is not the case, because DCA reawakened the mitochondria in cancer cells. The cells then withered and died.
"The results are intriguing because they point to a critical role that mitochondria play: they impart a unique trait to cancer cells that can be exploited for cancer therapy," says Dario Altieri, director of the University of Massachusetts Cancer Center in Worcester.
DCA can cause pain, numbness and gait disturbances in some patients, but this may be a price worth paying if it turns out to be effective against all cancers.
Watch video: Cancer Cure DCA Sodium Dichloroacetate (DCA) - The Cancer Cure!! BREAKING NEWS
#cancer, #DichloroaceticAcid , #DCA , #metabolic , #bigpharma
Information and image credit: wiki, newscientist, pslweb, try-again, cancergrace.